54 related articles for article (PubMed ID: 8595085)
1. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice.
Heitzmann T; Neidlein R; Freund P; Reiff K; Strein K
Arzneimittelforschung; 1995 Dec; 45(12):1284-8. PubMed ID: 8595085
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of some new oral blood glucose-lowering agents in dogs.
Heitzmann T; Neidlein R; Freund P; Reiff K; Strein K
Arzneimittelforschung; 1995 Nov; 45(11):1182-7. PubMed ID: 8929236
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the new oral blood glucose-lowering agent (-)-2-(4-tert.-butylphenoxy)-7-(4-chlorophenyl)-heptanic acid sodium salt in mice, rats and dogs.
Heitzmann T; Neidlein R; Freund P; Strein K
Arzneimittelforschung; 1995 Aug; 45(8):868-72. PubMed ID: 7575749
[TBL] [Abstract][Full Text] [Related]
4. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
Jajoo HK; Mamidi RN; Vakkalanka SV; Sathyavageeswaran S; Katneni K; Ayalasomayajula PS; Rao BP; Lohray BB; Subramaniam S
Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pharmacokinetic studies of the newly synthesized thiazolidinedione derivative 5-(4-(1-phenyl-1-cyclopropanecarbonylamino)benzyl)-thiazolidine-2 ,4-dio ne.
Ueda N; Nomura Y; Muta Y; Matsuzaki Y; Hayashibe M; Ino Y; Suzuki S; Kurumi M
Arzneimittelforschung; 1998 Jun; 48(6):651-7. PubMed ID: 9689422
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of MCC-555, a novel insulin sensitizer in beagle dog plasma by high-performance liquid chromatography with fluorescence detection.
Sun N; Lin M; Fan G; Hong Z; Lu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):35-9. PubMed ID: 16563883
[TBL] [Abstract][Full Text] [Related]
7. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
[TBL] [Abstract][Full Text] [Related]
8. Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.
Kiyota Y; Kondo T; Maeshiba Y; Hashimoto A; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1997 Jan; 47(1):22-8. PubMed ID: 9037439
[TBL] [Abstract][Full Text] [Related]
9. Novel euglycemic and hypolipidemic agents. 1.
Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
[TBL] [Abstract][Full Text] [Related]
10. Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans.
Cox PJ; Ryan DA; Hollis FJ; Harris AM; Miller AK; Vousden M; Cowley H
Drug Metab Dispos; 2000 Jul; 28(7):772-80. PubMed ID: 10859151
[TBL] [Abstract][Full Text] [Related]
11. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.
Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K
Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.
Izumi T; Enomoto S; Hosiyama K; Sasahara K; Shibukawa A; Nakagawa T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Jun; 277(3):1630-41. PubMed ID: 8667232
[TBL] [Abstract][Full Text] [Related]
14. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
Minoura H; Takeshita S; Ita M; Hirosumi J; Mabuchi M; Kawamura I; Nakajima S; Nakayama O; Kayakiri H; Oku T; Ohkubo-Suzuki A; Fukagawa M; Kojo H; Hanioka K; Yamasaki N; Imoto T; Kobayashi Y; Mutoh S
Eur J Pharmacol; 2004 Jun; 494(2-3):273-81. PubMed ID: 15212984
[TBL] [Abstract][Full Text] [Related]
16. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
[TBL] [Abstract][Full Text] [Related]
17. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
[TBL] [Abstract][Full Text] [Related]
18. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of pioglitazone in Thai healthy subjects.
Wittayalertpanya S; Chompootaweep S; Thaworn N
J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
Tanis SP; Parker TT; Colca JR; Fisher RM; Kletzein RF
J Med Chem; 1996 Dec; 39(26):5053-63. PubMed ID: 8978836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
